Signifier Medical Technologies Announces Participation In Goldman Sachs 2019 European Medtech Conference

snoozeal product controller and main product

London, United Kingdom
July 5, 2019 – Signifier Medical Technologies, a medical technology company developing innovative sleep disordered breathing products for use in the homecare setting, today announced that the Company’s management will be participating in the 16th Goldman Sachs European MedTech Conference in London in September 2019.

About Signifier Medical Technologies

Signifier Medical Technologies, previously known as Snoozeal, is a medical technology company focused on the development and commercialization of innovative and non-invasive solutions for patients with snoring and sleep disordered breathing conditions.

Signifier’s proprietary therapy is the first and only day time genioglossal muscle-neurostimulation technology, with proven clinical data from prestigious and well-recognised universities and academic institutions, that provides a safe and effective treatment for its patients.

For media enquiries:
+44 (0) 207 096 0586